Literature DB >> 2145253

N15-alkyl and N15,N15-dialkyl derivatives of teicoplanin antibiotics.

A Malabarba1, A Trani, J Kettenring, E Gerli, R Pallanza, M Berti, B Cavalleri.   

Abstract

The synthesis and the biological properties of a series of N15-alkyl and N15,N15-dialkyl derivatives of teicoplanin A2, its pseudoaglycones and aglycone are described. The alkylation of the terminal amino group did not affect the ability of these teicoplanin derivatives to bind with Ac2-L-Lys-D-Ala-D-Ala, a synthetic model of the antibiotic's target peptide in bacterial cell walls, but influenced their in vitro and in vivo antimicrobial activities to a different extent, depending on the structure and length of the alkyl chains and the type and number of sugars present.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145253     DOI: 10.7164/antibiotics.43.1107

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium.

Authors:  Zsolt Szűcs; Ilona Bereczki; Erzsébet Rőth; Márton Milánkovits; Eszter Ostorházi; Gyula Batta; Lajos Nagy; Zsuzsanna Dombrádi; Anikó Borbás; Pál Herczegh
Journal:  J Antibiot (Tokyo)       Date:  2020-05-15       Impact factor: 2.649

2.  Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.

Authors:  Jan Balzarini; Els Keyaerts; Leen Vijgen; Herman Egberink; Erik De Clercq; Marc Van Ranst; Svetlana S Printsevskaya; Eugenia N Olsufyeva; Svetlana E Solovieva; Maria N Preobrazhenskaya
Journal:  Antiviral Res       Date:  2006-04-06       Impact factor: 5.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.